由以下一般式表示的化合物:
1
[其中 A
g
是可选择地取代的5-至14-成员杂环基团,等等;X
g
是—O—,—S—,等等;Y
g
是可选择地取代的C
6
-
14
芳基团,可选择地取代的5-至14-成员杂环基团,等等;以及 T
g1
是由以下一般式表示的基团:
2
[其中 E
g
是单键或—N(R
g2
)—,R
g1
和R
g2
各自独立地表示氢原子,可选择地取代的C
1-6
烷基基团,等等,Z
g
表示C
1-8
烷基基团,C
3-8
脂环烃基团,C
6-14
芳基团,等等],
其盐或上述化合物的水合物。
由以下一般式表示的化合物:
1
[其中 A
g
是可选择地取代的5-至14-成员杂环基团,等等;X
g
是—O—,—S—,等等;Y
g
是可选择地取代的C
6
-
14
芳基团,可选择地取代的5-至14-成员杂环基团,等等;以及 T
g1
是由以下一般式表示的基团:
2
[其中 E
g
是单键或—N(R
g2
)—,R
g1
和R
g2
各自独立地表示氢原子,可选择地取代的C
1-6
烷基基团,等等,Z
g
表示C
1-8
烷基基团,C
3-8
脂环烃基团,C
6-14
芳基团,等等],
其盐或上述化合物的水合物。
The present invention relates to picolinic acid derivatives that are useful in treating fungal diseases ofplants.
本发明涉及烟酸衍生物,用于治疗植物的真菌性病害。
PYRIMIDYL DERIVATIVES AS PROTEIN KINASE INHIBITORS
申请人:Georges Guy
公开号:US20100041684A1
公开(公告)日:2010-02-18
Objects of the present invention are the compounds of formula (I), their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above compounds, medicaments containing them and their manufacture, as well as the use of the above compounds in the control or prevention of illnesses such as cancer.
Compounds represented by the following general formula:
[wherein A
g
is an optionally substituted 5- to 14-membered heterocyclic group, etc.; X
g
is —O—, —S—, etc.; Y
g
is an optionally substituted C
6-14
aryl group, an optionally substituted 5- to 14-membered heterocyclic group, etc.; and T
g1
is a group represented by the following general formula:
(wherein E
g
is a single bond or —N(R
g2
)—, R
g1
and R
g2
each independently represent a hydrogen atom, an optionally substituted C
1-6
alkyl group, etc. and Z
g
represents a C
1-8
alkyl group, a C
3-8
alicyclic hydrocarbon group, a C
6-14
aryl group, etc.)],
salts thereof or hydrates of the foregoing.
Compounds represented by the following general formula:
wherein A
g
is an optionally substituted 5- to 14-membered heterocyclic group, etc.; X
g
is —O—, —S—, etc.; Y
g
is an optionally substituted C
6-14
aryl group, an optionally substituted 5- to 14-membered heterocyclic group, etc.; and T
g1
is a group represented by the following general formula:
(wherein E
g
is a single bond or —N(R
g2
)—), R
g1
and R
g2
each independently represent a hydrogen atom, an optionally substituted C
1-6
alkyl group, etc. and Z
g
represents a C
1-8
alkyl group, a C
3-8
alicyclic hydrocarbon group, a C
6-14
aryl group, etc.), salts thereof or hydrates of the foregoing.
Compounds represented by the following general formula:
[wherein Ag is an optionally substituted 5- to 14-membered heterocyclic group, etc.; Xg is -O-, -S-, etc.; Yg is an optionally substituted C6-14 aryl group, an optionally substituted 5- to 14-membered heterocyclic group, etc.; and Tg1 is a group represented by the following general formula:
(wherein Eg is a single bond or -N(Rg2)-, Rg1 and Rg2 each independently represent a hydrogen atom, an optionally substituted C1-6 alkyl group, etc. and Zg represents a C1-8 alkyl group, a C3-8 alicyclic hydrocarbon group, a C6-14 aryl group, etc.)], salts thereof or hydrates of the foregoing.